ELF5 and DOK7 regulation in anti-estrogen treated cells and tumors

BACKGROUND: Most women with primary breast cancers that express estrogen receptor alpha (ER or ESR1) are treated with endocrine therapies including the anti-estrogen tamoxifen, but resistance to these anti-endocrine therapies often develops. This study characterizes the expression of hormone recepto...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Cell Int
Autors principals: Fitzgerald, Lily M., Browne, Eva P., Christie, Kevin D., Punska, Elizabeth C., Simmons, Leo O., Williams, Kristin E., Pentecost, Brian T., M. Jawale, Rahul, Otis, Christopher N., Arcaro, Kathleen F.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Primary Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4754800/
https://ncbi.nlm.nih.gov/pubmed/26884724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-016-0282-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars